Opt in or opt out: What is optimal for prenatal screening for HIV infection?

CMAJ. Canadian Medical Association Journal

Volumn 168, Issue 6, 2003, Pages 707-708

  Walmsley, Sharon ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; COST BENEFIT ANALYSIS; DECISION MAKING; FEMALE; GESTATION PERIOD; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; NOTE; POPULATION RESEARCH; PRENATAL SCREENING; RISK ASSESSMENT; VIRUS TRANSMISSION;

EID: 0037453039     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (25)

1. Watts DH. Management of human immunodeficiency virus infection in pregnancy. N Engl J Med 2002;346:1879-91.
2. US Department of Health and Human Services. Public Health Services Task Force recommendation for use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Rockville (MD): HIV/AIDS Treatment Information Service; 2002. Available: www.aidsinfo.nih.gov/guidelines/perinatal/petinatal-083002.html (accessed 2003 Feb 12).
3. Newell ML, Rogers M. Pregnancy and HIV infection: a European consensus on management. AIDS 2002;16:S1-18.
4. Division of HIV/AIDS Epidemiology and Surveillance, Centre for Infectious Disease Prevention and Control, Health Canada. Perinatal transmission of HIV. HIV/AIDS Epi Update series. Ottawa: Health Canada; 2002. p. 24-9. Available: www.hc-sc.gc.ca/pphb-dgspsp/publicat/epiu-aepi/hiv-vih/peri_e.html (accessed 2003 Feb 12).
5. King SM, Lapointe N, Forbes J, Samson L, Vaudry W, Singer J, et al, and the Canadian Pediatric AIDS Research Group. Are we close to elimination of prenatal HIV infection in Canada? [abstract]. Can J Infect Dis 2002;13:52A.
6. Postma MJ, Beck EJ, Mandalia S, Sherr L, Walters MD, Houweling H, et al. Universal HIV screening of pregnant women in England: cost effectiveness analysis. BMJ 1999;318:1656-60.
7. Ades AE, Gupta R, Gibb DM, Duong T, Nicoll A, Goldberg D, et al. Selective versus universal antenatal HIV testing: epidemiological and implementational factors in policy choice. AIDS 1999;13:271-8.
8. Postma MJ, Beck EJ, Hankins CA, Mandalia S, Jager JC, de Jong-van den Berg LT, et al. Cost effectiveness of expanded antenatal HIV testing in London. AIDS 2000;14:2383-9.
9. Patrick DM, Money DM, Forbes J, Dobson SR, Rekart ML, Cook DA, et al. Routine prenatal screening for HIV in a low-prevalence setting. CMAJ 1998;159(8):942-7.
10. Samson L, King S. Evidence-based guidelines for universal counselling and offeting of HIV testing in pregnancy in Canada. CMAJ 1998;158(11):1449-57.
11. Nakchbandi IA, Longenecker JC, Ricksecker MA, Latta RA, Healton C, Smith DG, et al. A decision analysis of mandatory compared with voluntary HIV testing in pregnant women. Ann Intern Med 1998;128:760-7.
12. Peckham CS, Newell ML. Controversy in mandatory HIV screening of pregnant women. Curr Opin Infect Dis 1997;10:18-21.
13. Committee on Perinatal Transmission of HIV and Commission on Behavioral and Social Sciences and Education, Institute of Medicine. Reducing the odds: preventing perinatal transmission of HIV in the United States. Washington: National Academy Press; 1999.
14. Simpson WM, Johnstone FD, Boyd FM, Goldberg DJ, Hart GJ, Prescott RJ. Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test. BMJ 1998;316:262-7.
15. Fernandez MI, Wilson TE, Ethier KA, Walter EB, Gay CL, Moore J, for the Perinatal Guidelines Evaluation Project. Acceptance of HIV testing during prenatal care. Public Health Rep 2000;115:460-8.
16. Carusi D, Learman LA, Posner SF. Human immunodeficiency virus test refusal in pregnancy: a challenge to voluntary testing. Obstet Gynecol 1998;91:540-5.
17. Kiarie J, Nduati R, Koigi K, Musia J, John G. HIV-1 testing in pregnancy: acceptability and correlates of return for test results. AIDS 2000;14:1468-70.
18. Bitnun A, King SM, Arneson C, Read SE. Failure to prevent perinatal HIV infection [letter]. CMAJ 2002;166(7):904-5.
19. Lo B, Wolf L, Sengupta S. Ethical issues in early detection of HIV infection to reduce vertical transmission. J Acquir Immune Defic Syndr Hum Retrovirol 2000;25:S136-43.
20. Simpson WM, Johnstone FD, Goldberg DJ, Gormley SM, Hart GJ. Antenatal HIV testing: assessment of a routine voluntary approach. BMJ 1999;318:1660-1.
21. Blott M, Yearwood J, Gerval M, Welch J, Zuckerman M. Routine antenatal HIV testing is acceptable to woman. BMJ 1999;319:1069-70.
22. Stringer EM, Stringer JS, Cliver SP, Goldenberg RL, Goepfert AR. Evaluation of a new testing policy for human immunodeficiency virus to improve screening rates. Obstet Gynecol 2001;98:1104-8.
23. Stringer E, Stringer J, Cliver S, Goldenberg R, Goepfert A. Active refusal increases human immunodeficiency virus screening in an urban prenatal clinic system. Obstet Gynecol 2001;97:S58.
24. Jayaraman GC, Preiksaitis JK, Larke B. Mandatory reporting of HIV infection and opt-out prenatal screening for HIV infection: effect on testing rates. CMAJ 2003;168(6):679-82.
25. Human immunodeficiency virus screening. Joint statement of the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. Pediatrics 1999;104(1 pt 1):128.